PubRank

Antonio Salvetti

Author PubWeight™ 56.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005 2.46
2 Endothelial function and dysfunction. Part I: Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005 2.12
3 Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 2003 1.61
4 Effect of oral contraceptives on endothelial function in the peripheral microcirculation of healthy women. J Hypertens 2003 1.49
5 Physical activity, plasma antioxidant capacity, and endothelium-dependent vasodilation in young and older men. Am J Hypertens 2005 1.49
6 Effect of sulfaphenazole on tissue plasminogen activator release in normotensive subjects and hypertensive patients. Circulation 2009 1.49
7 Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study. J Hypertens 2002 1.48
8 Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension 2003 1.48
9 Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 2003 1.43
10 Prevalence of left ventricular hypertrophy and determinants of left ventricular mass in obese women. High Blood Press Cardiovasc Prev 2012 1.42
11 Tissue-type plasminogen activator release in healthy subjects and hypertensive patients: relationship with beta-adrenergic receptors and the nitric oxide pathway. Hypertension 2008 1.39
12 Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism. J Hypertens 2008 1.39
13 [Hypertensive heart disease: diagnostic and therapeutic guidelines]. G Ital Cardiol (Rome) 2008 1.39
14 Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am J Hypertens 2007 1.36
15 The T-786C and Glu298Asp polymorphisms of the endothelial nitric oxide gene affect the forearm blood flow responses of Caucasian hypertensive patients. J Am Coll Cardiol 2003 1.33
16 Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 2006 1.29
17 Endothelial dysfunction and oxidative stress in chronic renal failure. J Nephrol 2004 1.17
18 Vascular generation of tumor necrosis factor-α reduces nitric oxide availability in small arteries from visceral fat of obese patients. J Am Coll Cardiol 2011 1.16
19 Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002 1.11
20 Identification of a cytochrome P450 2C9-derived endothelium-derived hyperpolarizing factor in essential hypertensive patients. J Am Coll Cardiol 2006 1.05
21 Arterial stiffness, intima-media thickness and carotid artery fibrosis in patients with primary aldosteronism. J Hypertens 2008 1.02
22 Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice. Hypertension 2006 1.02
23 Endothelium, aging, and hypertension. Curr Hypertens Rep 2006 0.97
24 Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 2007 0.96
25 Recombinant human thyrotropin reduces endothelium-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 2006 0.95
26 Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 2007 0.88
27 Vascular reactivity in congenital hypogonadal men before and after testosterone replacement therapy. J Clin Endocrinol Metab 2006 0.88
28 Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress. J Pharmacol Exp Ther 2004 0.88
29 Endothelial dysfunction in essential hypertension: clinical implications. J Hypertens 2002 0.86
30 Reduced left ventricular functional reserve in hypertensive patients with preserved function at rest. Hypertension 2005 0.85
31 Carotid vascular remodeling in patients with pheochromocytoma. J Clin Endocrinol Metab 2006 0.83
32 Primary aldosteronism in normokalemic patients with adrenal incidentalomas. Eur J Endocrinol 2002 0.83
33 Chronic treatment with long-acting nifedipine reduces vasoconstriction to endothelin-1 in essential hypertension. Hypertension 2006 0.82
34 Left ventricular diastolic dysfunction in elderly hypertensives: results of the APROS-diadys study. J Hypertens 2007 0.81
35 [Obesity and endothelial dysfunction]. G Ital Cardiol (Rome) 2006 0.81
36 Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens 2008 0.81
37 The role of the critical event committee in a major cardiovascular outcome study. Blood Press 2002 0.80
38 Ambulatory monitoring of systolic hypertension in the elderly: Eprosartan/hydrochlorothiazide compared with losartan/hydrochlorothiazide (INSIST trial). Adv Ther 2010 0.80
39 Endothelium-dependent vasodilation and carotid artery wall remodeling in athletes and sedentary subjects. Atherosclerosis 2005 0.80
40 Anthropometric, haemodynamic, humoral and hormonal evaluation in patients with incidental adrenocortical adenomas before and after surgery. Eur J Endocrinol 2003 0.79
41 Fixed dose combination of perindopril and indapamide improves peripheral vascular function in essential hypertensive patients. Am J Hypertens 2009 0.79
42 Normalization of catecholamine production following resection of phaeochromocytoma positively influences carotid vascular remodelling. Eur J Endocrinol 2008 0.79
43 Soy protein diet improves endothelial dysfunction in renal transplant patients. Nephrol Dial Transplant 2006 0.78
44 Nitric oxide modulates tissue plasminogen activator release in normotensive subjects and hypertensive patients. Hypertension 2007 0.78
45 Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients. J Cardiovasc Pharmacol 2003 0.78
46 Vascular reactivity in patients with undifferentiated connective tissue diseases. Atherosclerosis 2008 0.77
47 Myocardial ultrasonic backscatter in hypertension: relation to aldosterone and endothelin. Hypertension 2003 0.77
48 Which endothelium-derived factors are really important in humans? Biol Chem 2006 0.77
49 Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril. J Nephrol 2004 0.77
50 Current treatment of patients with hypertension: therapeutic implications of INSIGHT. Drugs 2003 0.76
51 Cardiac structural and functional changes during long-term antihypertensive treatment with lacidipine and atenolol in the European Lacidipine Study on Atherosclerosis (ELSA). J Hypertens 2005 0.76
52 Endothelial function in hypertension: role of gender. J Hypertens Suppl 2002 0.76
53 Cardiovascular parameter changes in patients with erectile dysfunction using pde-5 inhibitors: a study with sildenafil and vardenafil. J Androl 2004 0.76
54 Omega 3 : where do we stand? High Blood Press Cardiovasc Prev 2013 0.75
55 [Clinical significance of the assessment of endothelial function]. Ital Heart J Suppl 2004 0.75
56 Myocardial perfusion response to dipyridamole in hypertensive left ventricular hypertrophy: a human study using myocardial contrast echocardiography. Microvasc Res 2002 0.75
57 Plasma chromogranin A in incidental non-functioning, benign, solid adrenocortical tumors. Eur J Endocrinol 2004 0.75
58 Preclinical cardiac involvement in phaeochromocytoma: a study with integrated backscatter. Clin Endocrinol (Oxf) 2007 0.75
59 Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjects. J Hypertens 2006 0.75